Bacus SS - Search Results

1

Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.

Zhang L, Chang CJ, Bacus SS, Hung MC. Zhang L, et al. Among authors: bacus ss. Cancer Res. 1995 Sep 1;55(17):3890-6. Cancer Res. 1995. PMID: 7543819

2

Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers.

Xia W, Husain I, Liu L, Bacus S, Saini S, Spohn J, Pry K, Westlund R, Stein SH, Spector NL. Xia W, et al. Cancer Res. 2007 Feb 1;67(3):1170-5. doi: 10.1158/0008-5472.CAN-06-2101. Cancer Res. 2007. PMID: 17283152

3

Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.

Bacus SS, Stancovski I, Huberman E, Chin D, Hurwitz E, Mills GB, Ullrich A, Sela M, Yarden Y. Bacus SS, et al. Cancer Res. 1992 May 1;52(9):2580-9. Cancer Res. 1992. PMID: 1373672

4

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.

Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN, Bacus SS. Esteva FJ, et al. Among authors: bacus ss. Cancer. 2004 Feb 1;100(3):499-506. doi: 10.1002/cncr.11940. Cancer. 2004. PMID: 14745865 Free article. Clinical Trial.

5

Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.

Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL. Xia W, et al. Cancer Res. 2006 Feb 1;66(3):1640-7. doi: 10.1158/0008-5472.CAN-05-2000. Cancer Res. 2006. PMID: 16452223

6

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

Colomer R, Lupu R, Bacus SS, Gelmann EP. Colomer R, et al. Among authors: bacus ss. Br J Cancer. 1994 Nov;70(5):819-25. doi: 10.1038/bjc.1994.405. Br J Cancer. 1994. PMID: 7947086 Free PMC article.

7

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Cristofanilli M, et al. Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215537 Clinical Trial.

8

Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.

Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R, et al. Bacus SS, et al. Cancer Res. 1993 Nov 1;53(21):5251-61. Cancer Res. 1993. PMID: 8106145

9

A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.

Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R. Bacus SS, et al. Cell Growth Differ. 1992 Jul;3(7):401-11. Cell Growth Differ. 1992. PMID: 1358180

10

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K. Hunt KK, et al. Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23. Clin Cancer Res. 2017. PMID: 27881578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters